| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | endotoxin |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| KEGG |
|
 N Y (what is this?) (verify) | |
Nebacumab is a human monoclonal antibody developed for the treatment of sepsis.[1] It has been withdrawn in 1993 because it failed to reduce mortality in clinical trials.[2]
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Fungal |
| ||||||||
| Viral |
| ||||||||
| Bacterial |
| ||||||||
| Toxin |
| ||||||||
| |||||||||
|
Immune sera and immunoglobulins (J06)
| |||||
|---|---|---|---|---|---|
| Polyclonal antibodies |
| ||||
| Monoclonal antibodies |
| ||||
 | This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
